with multidrug-resistant tuberculosis emerging as a major obstacle in the fight against tuberculosis , doctors advocated the need for a collective movement to adopt appropriate diagnostic mechanisms that help in accurate diagnosis of strains resistant to drugs tuberculosis. leading specialists highlighted the growing threat of multidrug-resistant tuberculosis drugs in West Bengal, claiming that many gaps must be addressed – TB Diagnosis Management – to achieve 100% diagnosis, prevent patients leaving treatment mid way and ensure that drug resistant strains are identified timely and correct.
WHO statistics for 2014 suggest an estimated 2.2 million cases of tuberculosis in India of an overall incidence of incidence 9 million, so that 1 in 5 patients with tuberculosis throughout the world an Indian. In the developing world, including India, the burden of TB it has been further aggravated by the emergence of new drug-resistant tuberculosis (MDR-TB and XDR-TB) strains. According to estimates for 2014, TB cases with MDR-TB range of 2-3% of new cases and 11-19% of cases of tuberculosis retreatment with the rampant spread of disease. (Read: Why India needs to pay attention to the nutritional needs of patients with tuberculosis )
‘The emergence of multidrug-resistant tuberculosis has jeopardized the overall objectives of the eradication of tuberculosis. In India, already they are struggling with problems such as under-diagnosis and lack of completion of treatment, and drug resistance has offered a completely new paradigm of obstacles in the fight. Drug resistance makes treatment very difficult, since regimens second-line drugs to treat MDR-TB are the toxic, expensive and long. This has put emphasis on improving diagnostic mechanisms that can not only diagnose tuberculosis, but also to identify drug resistance in detail. Liquid culture tests have offered a new ray of hope in our fight against multidrug-resistant tuberculosis, ‘ said Dr. RK Das, Hony. Secretary General of West Bengal Tuberculosis Association. You may also like to read 6 Strategies that can fight TB epidemic in India .
“Apart from improving diagnosis, management of tuberculosis need a much better precision and execution. In many cases, the results of resistant tuberculosis care tuberculosis inadequate and irrational use of medicines that causes bacteria to develop resistance to drugs. In this regard, treatment regimens practiced in our country across the spectrum of health need a major overhaul to include strict protocols to prevent the development of drug resistance. To improve the result in the DR-TB cases supply quality, accessibility of patients and exit actions should be examined. With this scenario, extreme care must be enforced, while the treatment of patients. Patients should be monitored while in the regime and all prescriptions must be compatible with accurate and complete diagnosis with diagnostic tests approved by WHO, ‘ said Dr. Sudip Roy, consultant microbiologist and a laboratory in office, the Superspeciaility Medica, Calcutta Hospital.
Diagnosis drug resistant TB is possible today with testing drug susceptibility based TB MGIT identifying effectively drugs bacteria have resistance the. This demonstrates save the lives of many patients because it helps doctors skip unwanted drugs in their treatment protocol. The overall success rate of treatment for new patients with tuberculosis was estimated at 84% in 2014, while for patients retreatment (DR-TB) the treatment success rate was only 68%. (Read: 7 Signs and symptoms of tuberculosis should not ignore )
To build capacity in understanding this technology in India, the medical technology company BD has been working with the Program Revised National tuberculosis Control for growing tuberculosis and drug susceptibility testing in laboratories in India. Under this initiative, best practices are taught the use of BD MGIT TM Liquid culture systems, quality control and quality assurance of laboratory practices. “It is very important that patients are placed in the most appropriate after early diagnosis regime to ensure the best chance of patient recovery and control of tuberculosis resistant to drugs. Through our work with the Association of tuberculosis West Bengal state, we want to ensure that more people in India will be tested accurately and treated appropriately from the beginning, ‘ said Varun Khanna, CEO – India and South Asia, BD.
the BD MGIT ™ system supports culture and rapid confirmation identification of TB bacteria to call the critical mass of the patient. This system is compatible with all the range of first and second line drug Sensitivity Tests (including the newly approved drugs, as delamanid and Bedaquiline) on resistant strains and is backed with a database management system BD data, which may allow analytical epidemiology. It is particularly valuable in its ability not only to detect MDR / XDR-TB, but also to determine which drugs can be used to treat the patient. It is much more effective than any other approach and, therefore, is recommended for the diagnosis of tuberculosis in patients co-infected with tuberculosis and HIV, pediatric tuberculosis, tuberculosis extrapulmonary, and cases of smear-negative tuberculosis. (Read: Endobroncial ultrasound can help in diagnosing easy tuberculosis)
Image Source: Getty Images ( image for representation purposes only)
This article was originally published on thehealthsite, Read the original article here